| Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities? SCS Brandao, JOX Ramos, LT Dompieri, ETAM Godoi, JL Figueiredo, ... Cytokine & Growth Factor Reviews 58, 102-110, 2021 | 86 | 2021 |
| Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat T Wang, R Yi, LA Green, S Chelvanambi, M Seimetz, M Clauss Cardiovascular Pathology 24 (5), 279-282, 2015 | 78 | 2015 |
| HIV-Nef protein persists in the lungs of aviremic patients with HIV and induces endothelial cell death S Chelvanambi, NV Bogatcheva, M Bednorz, S Agarwal, B Maier, ... American journal of respiratory cell and molecular biology 60 (3), 357-366, 2019 | 41 | 2019 |
| HIV-Nef protein transfer to endothelial cells requires Rac1 activation and leads to endothelial dysfunction implications for statin treatment in HIV patients S Chelvanambi, SK Gupta, X Chen, BW Ellis, BF Maier, TM Colbert, ... Circulation research 125 (9), 805-820, 2019 | 24 | 2019 |
| Systems approach to discovery of therapeutic targets for vein graft disease: PPARα pivotally regulates metabolism, activation, and heterogeneity of macrophages and lesion … JL Decano, SA Singh, C Gasparotto Bueno, L Ho Lee, A Halu, ... Circulation 143 (25), 2454-2470, 2021 | 22 | 2021 |
| A disease-driver population within interstitial cells of human calcific aortic valves identified via single-cell and proteomic profiling JL Decano, Y Iwamoto, S Goto, JY Lee, JT Matamalas, A Halu, M Blaser, ... Cell Reports 39 (2), 2022 | 19 | 2022 |
| Lipoprotein (a) induces vesicular cardiovascular calcification revealed with single-extracellular vesicle analysis MA Rogers, SK Atkins, KH Zheng, SA Singh, S Chelvanambi, TH Pham, ... Frontiers in cardiovascular medicine 9, 778919, 2022 | 17 | 2022 |
| EMAPII monoclonal antibody ameliorates influenza A virus-induced lung injury H Lu, S Chelvanambi, C Poirier, J Saliba, KL March, M Clauss, ... Molecular Therapy 26 (8), 2060-2069, 2018 | 16 | 2018 |
| In silico Drug Screening Approach Using L1000-Based Connectivity Map and Its Application to COVID-19 T Asano, S Chelvanambi, JL Decano, MC Whelan, E Aikawa, M Aikawa Frontiers in Cardiovascular Medicine 9, 842641, 2022 | 5 | 2022 |
| Cellular Heterogeneity of Activated Primary Human Macrophages and Associated Drug–Gene Networks: From Biology to Precision Therapeutics JL Decano, E Maiorino, JT Matamalas, S Chelvanambi, BM Tiemeijer, ... Circulation 148 (19), 1459-1478, 2023 | 4 | 2023 |
| Viral bad news sent by evail M Clauss, S Chelvanambi, C Cook, R ElMergawy, N Dhillon Viruses 13 (6), 1168, 2021 | 4 | 2021 |
| Human Endogenous Retrovirus, SARS-CoV-2, and HIV Promote PAH via Inflammation and Growth Stimulation D Wang, MT Gomes, Y Mo, CC Prohaska, L Zhang, S Chelvanambi, ... International Journal of Molecular Sciences 24 (8), 7472, 2023 | 3 | 2023 |
| Slide-seq for spatially mapping gene expression. metabolic syndrome exacerbates group 2 pulmonary hypertension, and NAD metabolism is influenced by tissue origin S Chelvanambi, JM Hester, S Sharma, T Lahm, AL Frump American Journal of Respiratory Cell and Molecular Biology 62 (1), 112-114, 2020 | 3 | 2020 |
| Role Of Cxcr3 In The Apoptosis-Resistance Of Endothelial Progenitor Cells In Hiv-Induced Pulmonary Hypertension L Farkas, D Farkas, S Chelvanambi, C Cool, MA Clauss A67. BREAKDOWN: THE CELLULAR CONTRIBUTION TO PULMONARY HYPERTENSION, A2257-A2257, 2017 | 1 | 2017 |
| Endothelial Cell Specific Expression of HIV-Nef Induces Endothelial Senescence and Reduced Cardiac Output M Noda, S Chelvanambi, MA Clauss Circulation 148 (Suppl_1), A14459-A14459, 2023 | | 2023 |
| A Systems Approach to Target Discovery Identifies the Novel Role of lncRNA-SPANXA2-OT1 in Macrophage Chemotaxis PK Jha, LY Itto, A Vijay, A Lupieri, S Chelvanambi, Y Nakamura, ... Circulation 148 (Suppl_1), A13799-A13799, 2023 | | 2023 |
| Single-cell T cell receptor sequencing of paired tissue and blood samples reveals clonal expansion of CD8+ effector T cells in patients with calcific aortic valve disease F Bartoli-Leonard, S Chelvanambi, T Pham, ME Turner, MC Blaser, ... bioRxiv, 2023.07. 08.548203, 2023 | | 2023 |
| Single Cell Transcriptional-Epigenetic Profiling and Sub-Cellular Proteomics Demonstrate That HIV-Nef Extracellular Vesicles Modulate Human Macrophage Heterogeneity to Promote … S Chelvanambi, J Decano, R Ge, Y Yanagihara, M Whelan, A Jule, ... Circulation 146 (Suppl_1), A15540-A15540, 2022 | | 2022 |
| Development of Novel EMAP-II Neutralizing Antibody Therapy for HIV-Associated Pulmonary Hypertension via Abrogation of HIV-Nef Induced Pulmonary Endothelial Damage S Chelvanambi, M Noda, MA Clauss Circulation 146 (Suppl_1), A15659-A15659, 2022 | | 2022 |
| Compositions and methods for suppressing and/or treating hiv-infection and/or a related clinical condition thereof MA Clauss, BF Maier, S Chelvanambi US Patent App. 17/416,947, 2022 | | 2022 |
